Moreover, ibrutinib inhibits the development of neuroblastoma xenografts in nude mice, and the combination of ibrutinib with the anaplastic lymphoma kinase (ALK) inhibitor crizotinib increases the suppression [40]. Here, ALK is linked to neuroblastoma.